Mark MacMahon
Impact in
-
- Blood Pressure and Hypertension Studies
-
- Diabetes, Cardiovascular Risks, and Lipoproteins
Papers in ⓘ
-
- Pharmacovigilance and Adverse Drug Reactions 1
- Surgery 11
- Lipoproteins and Cardiovascular Health 6
- Cardiovascular Syncope and Autonomic Disorders 2
- Co-authors
- J.M. Dawson (1 shared paper)Rodney Bluestone (1 shared paper)Ralph H. Stern (1 shared paper)Bingbing Yang (1 shared paper)Neil Hounslow (1 shared paper)Stephen C. Olson (1 shared paper)Robert Abel (1 shared paper)Lindsey Cass (1 shared paper)
- Journals
- Journal of Hypertension (2 papers)Postgraduate Medical Journal (1 paper)The Journal of Clinical Pharmacology (1 paper)QJM (1 paper)Respiratory Medicine (1 paper)
- Partner nations
- United KingdomUnited StatesIreland
In The Last Decade
Mark MacMahon
16 papers receiving 366 citations
Peers
Comparison fields: 5 of 80
- Cardiology and Cardiovascular Medicine 96
- Endocrinology, Diabetes and Metabolism 66
- Surgery 156
- Hematology 32
- Gastroenterology 15
Countries citing papers authored by Mark MacMahon
This map shows the geographic impact of Mark MacMahon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark MacMahon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark MacMahon more than expected).
Fields of papers citing papers by Mark MacMahon
This network shows the impact of papers produced by Mark MacMahon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark MacMahon. The network helps show where Mark MacMahon may publish in the future.
Co-authors
The 25 scholars most cited alongside Mark MacMahon, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | A pilot study with simvastatin and folic acid/vitamin B12 in preparation for the Study of the Effectiveness of Additional Reductions in Cholesterol and Homocysteine (SEARCH). | 2000 | 72 |
| 2 | 2000 | 64 | |
| 3 | 1998 | 52 | |
| 4 | 1969 | 47 | |
| 5 | 2000 | 33 | |
| 6 | 2005 | 32 | |
| 7 | 1998 | 25 | |
| 8 | 1996 | 16 | |
| 9 | 1995 | 16 | |
| 10 | 1995 | 15 | |
| 11 | 1998 | 13 | |
| 12 | 2000 | 7 | |
| 13 | [Evaluation of trough/peak ratio of indapamide 1.5 mg sustained-release form assessed by ambulatory blood pressure monitoring]. | 1996 | 5 |
| 14 | 1999 | 2 | |
| 15 | 1995 | 2 | |
| 16 | 1993 | 1 |
About Mark MacMahon
Mark MacMahon is a scholar working on Toxicology, Surgery, Endocrinology, Diabetes and Metabolism, Endocrine and Autonomic Systems and Pulmonary and Respiratory Medicine, having authored 16 papers that have together received 402 indexed citations. Recurring topics across this work include Lipoproteins and Cardiovascular Health (6 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (2 papers), Cardiovascular Syncope and Autonomic Disorders (2 papers), Pharmacology and Obesity Treatment (2 papers), Pharmaceutical Economics and Policy (2 papers), Pharmacovigilance and Adverse Drug Reactions (1 paper), Phytochemicals and Medicinal Plants (1 paper) and Analytical Methods in Pharmaceuticals (1 paper). The work is most often cited by research in Cardiology and Cardiovascular Medicine (96 citations), Endocrinology, Diabetes and Metabolism (66 citations), Surgery (156 citations), Hematology (32 citations) and Gastroenterology (15 citations). Mark MacMahon has collaborated with scholars based in United Kingdom, United States and Ireland. Frequent co-authors include J.M. Dawson, Rodney Bluestone, Ralph H. Stern, Bingbing Yang, Neil Hounslow, Stephen C. Olson, Robert Abel, Lindsey Cass, Alan Bye and Kulasiri A. Gunawardena. Their work appears in journals such as Journal of Hypertension, Postgraduate Medical Journal, The Journal of Clinical Pharmacology, QJM and Respiratory Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.